Keyword Connections

fibrate

Journals

1

1 BMJ open

Research Groups

0

No Research Group Connected

Bibliographies

15

1 Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials.

2 TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate

3 Photodegradation mechanism and genetic toxicity of bezafibrate by Pd/g-C3N4 catalysts under simulated solar light irradiation: The role of active species

4 Integrative methylation score to identify epigenetic modifications associated with lipid changes resulting from fenofibrate treatment in families

5 Enhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymer

6 Clofibrate, a PPAR-α agonist, abrogates sodium fluoride-induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba-1/anti-calbindin signaling pathways.

7 Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic mice

8 Esrrg participates in the fibrate mediated activation of genes of lipid and lipo-protein metabolism in a human apoA-I transgenic mouse model: A pharmacogenomics approach

9 bezafibrate attenuates pressure overload-induced cardiac hypertrophy and fibrosis

10 fenofibrate enhances the in vitro differentiation of foxp3+ regulatory t cells in mice

11 comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: a randomized, open-label, multicenter clinical trial in indian population

12 effect of fenofibrate and niacin on particle size and high density lipoprotein cholesterol

13 effect of fenofibrate on blood pressure reduction

14 etofibrate but not controlled-release niacin decreases ldl cholesterol and lipoprotein (a) in type iib dyslipidemic subjects

15 simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence